These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 34767324)

  • 1. Antidepressants Effects on Pain in Parkinson Disease: A Systematic Review.
    Anghelescu BA; Todoran R; Terroba-Chambi C; Bruno V
    Clin Neuropharmacol; 2021 Nov-Dec 01; 44(6):210-215. PubMed ID: 34767324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine versus other anti-depressive agents for depression.
    Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD006533. PubMed ID: 23076926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis.
    Häuser W; Wolfe F; Tölle T; Uçeyler N; Sommer C
    CNS Drugs; 2012 Apr; 26(4):297-307. PubMed ID: 22452526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
    Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
    Smith KM; Eyal E; Weintraub D;
    JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
    J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease.
    Menza M; Dobkin RD; Marin H; Mark MH; Gara M; Buyske S; Bienfait K; Dicke A
    Mov Disord; 2009 Jul; 24(9):1325-32. PubMed ID: 19412944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome.
    Uçeyler N; Häuser W; Sommer C
    Arthritis Rheum; 2008 Sep; 59(9):1279-98. PubMed ID: 18759260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic management.
    Dobkin RD; Menza M; Bienfait KL; Gara M; Marin H; Mark MH; Dicke A; Friedman J
    Am J Geriatr Psychiatry; 2011 Mar; 19(3):222-9. PubMed ID: 20808132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review.
    Richards BL; Whittle SL; van der Heijde DM; Buchbinder R
    J Rheumatol Suppl; 2012 Sep; 90():21-7. PubMed ID: 22942325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of duloxetine on primary pain symptoms in Parkinson disease.
    Djaldetti R; Yust-Katz S; Kolianov V; Melamed E; Dabby R
    Clin Neuropharmacol; 2007; 30(4):201-5. PubMed ID: 17762316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
    Moonen AJ; Wijers A; Leentjens AF; Christine CW; Factor SA; Juncos J; Lyness JM; Marsh L; Panisset M; Pfeiffer R; Rottenberg D; Serrano Ramos C; Shulman L; Singer C; Slevin J; McDonald W; Auinger P; Richard IH
    Parkinsonism Relat Disord; 2014 Jun; 20(6):644-6. PubMed ID: 24679737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond pain: can antidepressants improve depressive symptoms and quality of life in patients with neuropathic pain? A systematic review and meta-analysis.
    Caruso R; Ostuzzi G; Turrini G; Ballette F; Recla E; Dall'Olio R; Croce E; Casoni B; Grassi L; Barbui C
    Pain; 2019 Oct; 160(10):2186-2198. PubMed ID: 31145210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review.
    Leentjens AF
    Drugs; 2011 Feb; 71(3):273-86. PubMed ID: 21319866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
    Fava M; Mallinckrodt CH; Detke MJ; Watkin JG; Wohlreich MM
    J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant therapy for unexplained symptoms and symptom syndromes.
    O'Malley PG; Jackson JL; Santoro J; Tomkins G; Balden E; Kroenke K
    J Fam Pract; 1999 Dec; 48(12):980-90. PubMed ID: 10628579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Choices and Advancements for Managing Depression in Parkinson's Disease.
    Assogna F; Pellicano C; Savini C; Macchiusi L; Pellicano GR; Alborghetti M; Caltagirone C; Spalletta G; Pontieri FE
    Curr Neuropharmacol; 2020; 18(4):277-287. PubMed ID: 31622207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressants for depression in medical illness.
    Gill D; Hatcher S
    Cochrane Database Syst Rev; 2000; (4):CD001312. PubMed ID: 11034712
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.